SCHEMBL7690226

SCHEMBL7690226

O=C(NCC(=O)C(Cc1ccccc1)NC(=O)c1ccccc1C=Cc1ccncc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 11/20 0.53
CTSB P07858 6/20 0.50
CTSL P07711 5/20 0.49
CTSS P25774 4/20 0.49
CTSK P43235 3/20 0.49
ACE P12821 2/20 0.42
CTSV O60911 1/20 0.41
ROCK2 O75116 1/20 0.41
RPS6KA5 O75582 1/20 0.41
RPS6KA4 O75676 1/20 0.41
PRKACA P17612 1/20 0.41
MAPK1 P28482 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
IRAK1 P51617 1/20 0.41
PRKX P51817 1/20 0.41
ROCK1 Q13464 1/20 0.41
PRKG1 Q13976 1/20 0.41
PKN2 Q16513 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7688889 1.00 CAPN1 (0.53) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7690558 0.93 CAPN1 (0.60) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7697556 0.90 CAPN1 (0.53) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7693583 0.86 CAPN1 (0.48) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7696964 0.85 CAPN1 (0.61) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7688971 0.85 CAPN1 (0.51) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7693068 0.85 CAPN1 (0.70) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7696618 0.84 CAPN1 (0.51) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7693964 0.84 CAPN1 (0.50) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7689993 0.83 CAPN1 (0.74) CAPN1CTSBCTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed